MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-DL-08-0008135
Eydia Cure Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹11.02 Cr
▲ 245% YoY
Net profit · FY 2024
₹29.2 Lakh
Net margin 2.6%
EBITDA · FY 2024
₹32.02 Lakh
EBITDA margin 2.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹14.81 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
19
Provident fund records
About Eydia Cure Private Limited
Data last updated:
Eydia Cure Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2020PTC368740. Its GSTIN is 07AAGCE0488H1ZK (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ejazul Hasan and Mohd Danish Israr.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 127 Basement Dda Sheds Okhla Industrial Area Phase – 1, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.02 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹29.2 Lakh (net margin 2.6%) and EBITDA of ₹32.02 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 492% over three years.
The company has about 19 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Eydiacure. As per MCA filings, the company has open charges of ₹14.81 Lakh on record.
Eydia Cure Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-DL-08-0008135). For more details, the company can be reached via its website eydiacure.com.
Company details
CIN U24290DL2020PTC368740
Registration Number 368740
Incorporation Date 26 August 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-DL-08-0008135
Recognitions & Rankings of Eydia Cure
Contact details
Eydia Cure Private Limited's registered office is in New Delhi, Delhi. Its website is eydiacure.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB – 127 Basement Dda Sheds Okhla Industrial Area Phase – 1, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Eydia Cure Private Limited, buy the company report.
Comprehensive company report
Eydia Cure Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Eydia Cure operates one associated brand: Eydiacure. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and supplying pharmaceutical products for healthcare services. | eydiacure.com |
Business activity
The main business activity of Eydia Cure is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Eydia Cure Private Limited, buy the company report.
Financials of Eydia Cure Private Limited
FY 2025 filings availableEydia Cure Private Limited reported revenue of ₹11.02 Cr (up 245% YoY) for FY 2024.
Revenue · FY 2024
₹11.02 Cr ▲ 245%
Net profit · FY 2024
₹29.2 Lakh margin 2.6%
EBITDA · FY 2024
₹32.02 Lakh margin 2.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 245%
3 years · compounded
▲ 492%
EBITDA CAGR growth
1 year
▲ 205%
3 years · compounded
▲ 774%
Revenue has grown at a compounded annual rate (CAGR) of 492% over three years, including 245% growth in the latest year. EBITDA rose 205% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹32.02 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹29.2 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.9% | |||
| Net Profit Margin | 2.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Eydia Cure Private Limited, buy the company report.
Board of directors of Eydia Cure Private Limited
Eydia Cure has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ejazul Hasan Also directs: Innovega Pharma Private Limited | Director | 10 Aug 2021 | 5 Years 2 Months | Current |
| Mohd Danish Israr Also directs: Innovega Pharma Private Limited | Director | 10 Aug 2021 | 5 Years 2 Months | Current |
| Anant Kumar Pandey Also directs: Innovega Pharma Private Limited | Director | 10 Aug 2021 | 5 Years 2 Months | Current |
| Nitin Also directs: Innovega Pharma Private Limited | Director | 06 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Eydia Cure Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Marvel Drugs Pvt Ltd | ₹11.53 Cr (FY 2025) | -25.0% | Mumbai, Maharashtra, India | |||
| Vanshika Laboratories Private Limited | ₹11.45 Cr (FY 2025) | 30.0% | Sangareddy, Telangana, India | |||
| Arrow Powder Coats India Private Limited | ₹11.09 Cr (FY 2025) | 70.0% | Nagpur, Maharashtra, India | |||
| Okay Auxipol Private Limited | ₹11.08 Cr (FY 2025) | 77.0% | Mumbai, Maharashtra, India | |||
| White Line Chemicals Private Limited | ₹11.05 Cr (FY 2025) | -21.0% | Delhi, India | |||
| Eydia Cure Private Limitedthis company | ₹11.02 Cr (FY 2024) | ₹29.2 Lakh | 2.6% | 245.0% | New Delhi, Delhi, India | |
| Biotime Pharmaceuticals Private Limited | ₹10.93 Cr (FY 2025) | 716.0% | Ambernath, Maharashtra, India | |||
| S.A.E. Global Private Limited | ₹10.9 Cr (FY 2025) | 40125.0% | Delhi, India | |||
| Extra Blue Private Limited | ₹10.82 Cr (FY 2025) | 105.0% | Jamshedpur, Jharkhand, India | |||
| Nuvo Medsurg Private Limited | ₹10.67 Cr (FY 2024) | 5.0% | New Delhi, Delhi, India | |||
| Kuemen Laboratories Private Limited | ₹10.6 Cr (FY 2025) | 22.0% | New Delhi, Delhi, India |
To see the full peer comparison of Eydia Cure Private Limited, buy the company report.
Auditor
Eydia Cure Private Limited is audited by S K A G AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S K A G AND ASSOCIATES | FY 2023 | 558043 |
Shareholding
The shareholding of Eydia Cure Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Eydia Cure Private Limited, buy the company report.
Charges & borrowings
Open charges
₹14.81 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Dec 2023 | 100837743 | Hdfc Bank Limited | ₹14.81 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Eydia Cure Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eydia Cure Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Eydia Cure has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCE0488H1ZK | Delhi | Active | 26 Sep 2020 |
To see the full GST registrations and return filing status of Eydia Cure Private Limited, buy the company report.
Recent activity
Eydia Cure Private Limited has 7 board changes on record since 2021: 4 appointments and 3 cessations. The latest: Nitin was appointed as Director on 06 May 2023.
AGM
Eydia Cure Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Eydia Cure Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 14.81 Lakh with Charge ID 100837743 was registered on 13 Dec 2023.
Appointed
Nitin was appointed as Director.
Ceased
Akanksha Tripathi ceased to be Director.
Ceased
Alia Aziz ceased to be Managing Director.
Ceased
Kashif Israr ceased to be Director.
Appointed
Anant Kumar Pandey was appointed as Director.
Appointed
Ejazul Hasan was appointed as Director.
Appointed
Mohd Danish Israr was appointed as Director.
Incorporation
26 Aug 2020
Eydia Cure Private Limited was registered on 26 Aug 2020 with Roc Delhi & aged 6 years 1 month as per MCA records.
Frequently asked questions
Eydia Cure is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 August 2020 (6+ years old) and is registered under CIN U24290DL2020PTC368740.
Eydia Cure has 4 current directors:
- Ejazul Hasan - Director
- Mohd Danish Israr - Director
- Anant Kumar Pandey - Director
- Nitin - Director
The latest financial statements of Eydia Cure on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Eydia Cure is 07AAGCE0488H1ZK, registered in Delhi.
The CIN (Corporate Identification Number) of Eydia Cure is U24290DL2020PTC368740. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eydia Cure was incorporated on 26 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Eydia Cure by revenue are Marvel Drugs Pvt Ltd, Vanshika Laboratories Private Limited, Arrow Powder Coats India Private Limited, Okay Auxipol Private Limited, White Line Chemicals Private Limited and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Nitin was appointed as Director on 06 May 2023. Akanksha Tripathi ceased to be Director on 12 Aug 2021. Alia Aziz ceased to be Managing Director on 12 Aug 2021. Eydia Cure has 7 board changes on record in total.
Yes, Eydia Cure is registered as an MSME under Udyam registration (number: UDYAM-DL-08-0008135).
Eydia Cure can be reached through the website eydiacure.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Eydia Cure is at B – 127 Basement Dda Sheds Okhla Industrial Area Phase – 1, New Delhi, Delhi, India – 110020.